Pancreatic Cancer Archives

source: shutterstock.com

Rare Community Profiles: How the Seena Magowitz Foundation is Working to Change the World for People Living with Pancreatic Cancer

Post author:Jessica Lynn
Post published:June 6, 2023
Post category:Pancreatic Cancer

Rare Community Profiles Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

mohamed_hassan / Pixabay

Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer

Post author:Jessica Lynn
Post published:May 19, 2023
Post category:Pancreatic Cancer

On May 18, 2023, Market Watch reported that rucosopasem manganese received Orphan Drug designation. Developed by clinical stage biopharmaceutical company Galera Therapeutics (“Galera”), rucosopasem manganese is largely being developed…

skeeze / Pixabay

PYX-201 Granted Orphan Drug Designation for the Treatment of Pancreatic Cancer

Post author:Jessica Lynn
Post published:May 18, 2023
Post category:Pancreatic Cancer Timely

Pyxis Oncology is driven to improve the lives of people living with cancer through the development of innovative immunotherapy and antibody drug conjugate (ADJ) therapies. Their treatment PYX-201, a novel…

source: shutterstock.com

Some Pancreatic Cancer Patients Receiving Chemo May Benefit from Antibiotics

Post author:James Moore
Post published:May 5, 2023
Post category:Pancreatic Cancer

According to a story from Healio, a recent study found that patients with metastatic pancreatic cancer (more specifically, pancreatic ductal adenocarcinoma, the most common form) that were being treated with…

felljagd3150 / Pixabay

ICYMI: Pancreatic and Thyroid Cancer Coverage Now Provided for Ontario Firefighters

Post author:Jessica Lynn
Post published:April 19, 2023
Post category:Pancreatic Cancer Thyroid Cancer

The International Association of Fire Fighters (IAFF) shared in March 2023 that firefighters in Ontario would now have presumptive pancreatic cancer and thyroid cancer coverage. Presumptive coverage means that…

source: pixabay.com

Study of the Week: These Biomarkers Could be Used to Predict the Development of Pancreatic Cancer

Post author:James Moore
Post published:April 17, 2023
Post category:Pancreatic Cancer

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

TheDigitalArtist / Pixabay

Scientists Identify Biomarkers to Predict Pancreatic Cancer Development

Post author:Jessica Lynn
Post published:April 10, 2023
Post category:Pancreatic Cancer

Cases of pancreatic cancer have been increasing throughout the United States over the past few decades. Although the 5-year survival rate recently rose to 12%, pancreatic cancer is on track…

mohamed_hassan / Pixabay

Osemitamab for Pancreatic Cancer Granted Orphan Drug Designation

Post author:Jessica Lynn
Post published:April 10, 2023
Post category:Pancreatic Cancer

In the United States, Orphan Drug designation is granted by the U.S. Food and Drug Administration (FDA) to drugs or biologics that are being developed for rare conditions. Rare…

mohamed_hassan / Pixabay

Batiraxcept Earns Orphan Drug Designation for Pancreatic Cancer

Post author:Jessica Lynn
Post published:March 8, 2023
Post category:Pancreatic Cancer

In the United States, Orphan Drug designation is granted to drugs or biologics designed to treat, prevent, or diagnose rare conditions. “Rare” conditions refer to those affecting under 200,000…

source: pixabay.com

ICYMI: Having PCOS Could Raise Your Pancreatic Cancer Risk

Post author:Jessica Lynn
Post published:February 27, 2023
Post category:Pancreatic Cancer Polycystic Ovary Syndrome

In the past, research has found connections between polycystic ovary syndrome (PCOS) and pancreatic cancer. For example, one study suggested that having PCOS could increase pancreatic cancer risk by…

Five-Year Survival Rate Rises for Pancreatic Cancer

Post author:Jessica Lynn
Post published:February 16, 2023
Post category:Pancreatic Cancer

Pancreatic cancer unfortunately comes with a poor prognosis. It is the third leading cause of cancer-related deaths within the United States, though it is on track to become the second…

mohamed_hassan / Pixabay

QN-302 Granted Orphan Drug Designation for Pancreatic Cancer

Post author:Jessica Lynn
Post published:January 20, 2023
Post category:Pancreatic Cancer

In the United States, the Food and Drug Administration (FDA) grants Orphan Drug designation to drugs or biologics which intend to treat, diagnose, or prevent rare conditions. “Rare” conditions are…

Source: Pixabay

INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 4)

Post author:Jessica Lynn
Post published:January 12, 2023
Post category:Breast Cancer Pancreatic Cancer

Before you read on, make sure to check out: Part 1: Green Bay Packers' Shemar Jean-Charles and Los Angeles Chargers' Storm Norton talk about the importance of Alzheimer's disease awareness. …

source: pixabay.com

An Exciting New Procedure That Could Make an Impact on Pancreatic Cancer

Post author:Rose Duesterwald
Post published:December 26, 2022
Post category:Pancreatic Cancer

Contrary to simply stopping tumor growth, the biomedical engineers at Duke University have successfully demonstrated a new treatment for pancreatic cancer in a mouse model that may make a…

Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent

Post author:Rose Duesterwald
Post published:December 12, 2022
Post category:Pancreatic Cancer

Medscape Medical News reports that results have been received from the OCCLURANDOM Phase 2 trial which is the first randomized trial investigating the antitumor effect of the peptide receptor radionuclide…

mohamed_hassan / Pixabay

PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer

Post author:Jessica Lynn
Post published:December 9, 2022
Post category:Pancreatic Cancer

Are there therapeutic options for patients living with unresectable (inoperable) pancreatic cancer? According to an article in MedScape, researchers sought to understand whether sunitinib or a combination of peptide receptor…

https://pixabay.com/en/dna-helix-curve-science-medicine-869109/

ATG-101 for Pancreatic Cancer Earns Orphan Drug Designation

Post author:Jessica Lynn
Post published:September 29, 2022
Post category:Pancreatic Cancer

In the United States, the FDA grants Orphan Drug designation to drugs or biologics intended to prevent, diagnose, or treat rare conditions. These are conditions affecting fewer than 200,000 Americans.…

mohamed_hassan / Pixabay

SY-5609 for Relapsed Metastatic Pancreatic Cancer Earns Orphan Drug Designation

Post author:Jessica Lynn
Post published:September 23, 2022
Post category:Pancreatic Cancer

The Orphan Drug Act of 1983 was designed to facilitate the development of orphan drugs, or drugs designed for patients with rare or life-threatening conditions. Now, the FDA grants…

source: pixabay.com

Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers

Post author:Rose Duesterwald
Post published:September 5, 2022
Post category:Glioblastoma Ovarian Cancer Pancreatic Cancer

Dr. Jung-Mo Ahn, associate professor at Dallas University in Texas, created a molecule that kills a broad range of treatment-resistant cancers. The newly targeted group includes triple-negative breast cancer.…

source: pixabay.com

Study of the Week: Could This Protein Predict Diabetes and Cancer Death Risk?

Post author:James Moore
Post published:August 15, 2022
Post category:Cancer Endometrial cancer Hepatocellular Carcinoma Pancreatic Cancer

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

source: pixabay.com

Study of the Week: Three Part Treatment Strategy for Pancreatic Cancer Shows Potential in Mice

Post author:James Moore
Post published:August 8, 2022
Post category:Pancreatic Cancer

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

moreharmony / Pixabay

A Novel 3-Step Treatment Improves Pancreatic Cancer in Mice Models

Post author:Jessica Lynn
Post published:August 4, 2022
Post category:Pancreatic Cancer

In recent years, there have been advances in the treatment of pancreatic cancer. This is crucial, as the prognosis for this cancer is often poor, and the cancer itself is…

A Novel Treatment for Pancreatic Cancer, a Deadly Disease

Post author:Rose Duesterwald
Post published:June 15, 2022
Post category:Pancreatic Cancer

Pancreatic cancer is one of the deadliest forms of cancer. According to the American Cancer Society (ACS), only about 11% of patients are expected to survive more than five years…

source: pixabay.com

FDA Orphan Drug Designation for AML and Pancreatic Cancer Treatment Possibly More Effective Than Chemotherapy

Post author:Trudy Horsting
Post published:June 1, 2022
Post category:Acute Myeloid Leukemia Pancreatic Cancer

The FDA has just provided AB001 the Orphan Drug designation for both acute myeloid leukemia (AML) and pancreatic cancer. This small molecule was developed by Vopec Pharmaceuticals and Agastiya Biotech.…

The PanCAN PurpleStride Walk in Detroit Demonstrates the Resolve of Pancreatic Cancer Patients

Post author:Trudy Horsting
Post published:May 31, 2022
Post category:Pancreatic Cancer

In Detroit, activists recently came together to raise money for pancreatic cancer research through a walk called “The PanCAN PurpleStride walk.” Each year about 62,000 people are newly diagnosed with pancreatic…

Rare Community Profiles: How the Seena Magowitz Foundation is Working to Change the World for People Living with Pancreatic Cancer

Rucosopasem Manganese Granted Orphan Drug Designation for Pancreatic Cancer

PYX-201 Granted Orphan Drug Designation for the Treatment of Pancreatic Cancer

Some Pancreatic Cancer Patients Receiving Chemo May Benefit from Antibiotics

ICYMI: Pancreatic and Thyroid Cancer Coverage Now Provided for Ontario Firefighters

Study of the Week: These Biomarkers Could be Used to Predict the Development of Pancreatic Cancer

Scientists Identify Biomarkers to Predict Pancreatic Cancer Development

Osemitamab for Pancreatic Cancer Granted Orphan Drug Designation

Batiraxcept Earns Orphan Drug Designation for Pancreatic Cancer

ICYMI: Having PCOS Could Raise Your Pancreatic Cancer Risk

Five-Year Survival Rate Rises for Pancreatic Cancer

QN-302 Granted Orphan Drug Designation for Pancreatic Cancer

INTERVIEWS: NFL Players Discuss the Rare, Chronic, and Underserved Causes that Mean the Most to Them (Pt. 4)

An Exciting New Procedure That Could Make an Impact on Pancreatic Cancer

Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent

PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer

ATG-101 for Pancreatic Cancer Earns Orphan Drug Designation

SY-5609 for Relapsed Metastatic Pancreatic Cancer Earns Orphan Drug Designation

Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers

Study of the Week: Could This Protein Predict Diabetes and Cancer Death Risk?

Study of the Week: Three Part Treatment Strategy for Pancreatic Cancer Shows Potential in Mice

A Novel 3-Step Treatment Improves Pancreatic Cancer in Mice Models

A Novel Treatment for Pancreatic Cancer, a Deadly Disease

FDA Orphan Drug Designation for AML and Pancreatic Cancer Treatment Possibly More Effective Than Chemotherapy

The PanCAN PurpleStride Walk in Detroit Demonstrates the Resolve of Pancreatic Cancer Patients

X-Linked Hypophosphatemia: Unnderstanding this Hereditary, Progressive, and Lifelong Condition

Catalyst’s LEMS Aware Podcast Helps Connect Patients

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

Let’s Work Together!

Keep Up to Date

Learn More